Late-stage chronic kidney disease market (CKD) - Market research Report - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Late-stage chronic kidney disease market (CKD) - Market research Report

Description:

Due to loss of patent for major brands in the late-stage chronic kidney disease (CKD) market, and the changing reimbursement environment across the six major markets (6MM), the CKD sales revenue is forecasted to decrease at a negative CAGR of 2.5% between 2012 and 2017. The late-stage CKD therapeutics market in the 6MM (US, France, Germany, Italy, Spain, and UK) will decline from USD 1.88 billion in 2012 to USD 1.66 billion by 2017. It is expected that the majority of sales in the will still come from the US (76%), with marginal increase in the 5EU’s share (24%) during 2012 to 2017. Visit : – PowerPoint PPT presentation

Number of Views:144

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Late-stage chronic kidney disease market (CKD) - Market research Report


1
(No Transcript)
2
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Insights
  • The late-stage Chronic Kidney Disease (CKD)
    therapeutics market in the 6MM is forecasted to
    decline from USD 1.88 bn in 2012 to USD 1.66 bn
    in 2017, at a CAGR of -2.5
  • This decline is attributed to the loss of patent
    protection for major brands and tightening
    reimbursement environment for oral treatments in
    dialysis patients
  • With the expected launch of three novel pipeline
    agents, the dialysis CKD market segment is due to
    become increasingly competitive by 2017, as these
    agents enter a heavily genericized market

3
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Coverage
  • Overview of late-stage CKD, including
    epidemiology, etiology, pathophysiology,
    symptoms, diagnosis, and disease management
  • Top line late-stage CKD therapeutics market
    revenue from 2012-2017
  • Annual cost of therapy, and major marketed and
    pipeline drug sales in this forecast period are
    included
  • Key topics covered include strategic competitor
    assessment, market characterization, unmet needs,
    RD strategies, and clinical trial design for the
    late-stage CKD therapeutics market
  • Pipeline analysis of comprehensive data split
    across different phases, emerging novel trends
    under development

4
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Coverage (Continued)
  • Synopses of innovative early-stage projects and
    detailed analysis of late-stage pipeline drugs
  • Analysis of the current and future market
    competition in the global late-stage CKD
    therapeutics market
  • Insightful review of the key industry drivers,
    restraints and challenges
  • Each trend is independently researched to provide
    qualitative analysis of its implications

5
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Benefits
  • Develop and design in-licensing and out-licensing
    strategies through a review of pipeline products
    and technologies, and by identifying the
    companies with the most robust pipeline
  • Develop business strategies by understanding the
    trends shaping and driving the global late-stage
    CKD therapeutics market
  • Drive revenues by understanding the key trends,
    innovative products and technologies, market
    segments, and companies likely to impact the
    global late-stage CKD therapeutics market in the
    future
  • Formulate effective sales and marketing strategies

6
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Benefits (Continued)
  • Understand the competitive landscape by analysing
    the performance of various competitors
  • Identify emerging players with potentially strong
    product portfolios and create effective
    counter-strategies to gain a competitive
    advantage
  • Organize sales and marketing efforts by
    identifying the market categories and segments
    that present maximum opportunities for
    consolidations, investments and strategic
    partnerships

7
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Table of Contents
  • Introduction 
  • Disease Overview
  • Epidemiology 
  • Current Treatment Options
  • Unmet Needs Assessment and Opportunity Analysis
  • RD Strategies
  • Pipeline Assessment
  • Pipeline Valuation Analysis
  • Appendix 

8
Report Opportunity Analyzer Late-Stage Chronic
Kidney Disease (CKD) - Opportunity Analysis and
Forecasts to 2017
Report Details
  • Publish date 15th Nov, 2013
  • Number of slides 226
  • Geographic coverage Global
  • Available format PDF, CD, Hardcopy
  • Price for Single User License USD 5,995
  • Price for Site License USD 11,990
  • Price for Global User License USD 17,985
  • Delivery Time Within 1 business day
  • Payment Modes Credit/Debit Card, RTGS/Wire
    Transfer, Google Wallet, PayPal

9
Interested in this report?
To view more details regarding this premium
market research report, Please click here
For further information, get in touch with us
E-mail support_at_researchonglobalmarkets.com Call
US 1 866 325 7446 UK 44 203 514 2363 Others
91 22 4098 7600
About Us Research on Global Markets is a leading
source for market research on various sectors
globally offering premium research content from
worldwide publishers of market research reports
Industry Segments Industry Segments Industry Segments
Automotive Transport Consumer goods Agriculture
Food and Beverage Energy and Utilities Public Sector
Manufacturing Construction Healthcare Media Entertainment
IT, Telecom Electronics Services Others
About PowerShow.com